From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea.

Wall Street edged lower after getting pulled in opposite directions as President Donald Trump’s latest tariff escalation ...

Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...

Wall Street is getting pulled in different directions Thursday as President Donald Trump’s latest tariff escalation creates ...

A £1 billion profit by Next today illuminated an otherwise poor FTSE 100 session as stock market volatility returned on the ...

US stocks closed lower Wednesday as President Trump prepared to unveil new tariffs on US auto imports. The benchmark S&P 500 ...

The American renewable energy sector has been growing at a staggering pace and the country brought online 48.2 gigawatts of capacity from utility-scale solar, wind, and battery storage last year, ...

Tariffs could hurt the company's gross margins, according to BofA Securities, which noted that the core Dollar Tree brand imports around 41% to 43% of its total retail-value purchases, compared with ...

KB Home (KBH) stock is eyeing its worst day since 2022 after missing fiscal first-quarter earnings and revenue estimates ...

Jon Smith flags up a growth stock that he thinks could rally after it experienced a short-term fall following the release of ...

The Shenzhen-based firm has emerged in recent years as the clear leader in China's highly competitive EV market, which is the ...

In the past two months, shares of Colgate Palmolive (India), the market leader in oral care in the country, has ...